Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Frontiers Media SA full text link Frontiers Media SA Free PMC article
Full text links

Actions

Review
.2014 Jan 7:4:508.
doi: 10.3389/fimmu.2013.00508.

The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells

Affiliations
Review

The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells

Cristina Cerboni et al. Front Immunol..

Abstract

NKG2D and DNAM-1 are two activating receptors, present on the surface of NK cells and other cells of the immune system. Their ligands - MICA, MICB, ULBP1-6 for NKG2D, PVR/CD155 and Nectin-2/CD112 for DNAM-1 - can be constitutively expressed at low levels in some normal cells, but they are more often defined as "stress-induced," since different stimuli can positively regulate their expression. In this review, we describe the molecular mechanisms involved in the up-regulation of NKG2D and DNAM-1 ligands under different physiological and pathological "stress" conditions, including mitosis, viral infections, and cancer. We will focus on the DNA damage response, as recent advances in the field have uncovered its important role as a common signaling pathway in the regulation of both NKG2D and DNAM-1 ligand expression in response to very diverse conditions and stimuli.

Keywords: DNA damage response; DNAM-1 ligands; NK cells; NKG2D ligands; stress.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of the variety of stimuli that can up-regulate NKG2D and DNAM-1 ligands. There is evidence that both in normal cells (e.g., antigen-activated T lymphocytes), as well as in pathological conditions, including virally-infected cells (in particular with HIV-1) and cancer cells, a major regulatory pathway involved in ligand up-regulation is the DNA damage response (DDR), activated by different stimuli. The increased expression of activating ligands has been shown to be implicated in the recognition and elimination of “stressed” cells by NK cells, and presumably also by other cytotoxic cells (i.e., γδ T cells and CD8+ T cells).
See this image and copyright information in PMC

References

    1. Champsaur M, Lanier LL. Effect of NKG2D ligand expression on host immune responses. Immunol Rev (2010) 235(1):267–8510.1111/j.0105-2896.2010.00893.x - DOI - PMC - PubMed
    1. Gleimer M, Parham P. Stress management: MHC class I and class I-like molecules as reporters of cellular stress. Immunity (2003) 19(4):469–7710.1016/S1074-7613(03)00272-3 - DOI - PubMed
    1. Zingoni A, Ardolino M, Santoni A, Cerboni C. NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses. Front Immunol (2012) 3:408.10.3389/fimmu.2012.00408 - DOI - PMC - PubMed
    1. Baychelier F, Vieillard V. The modulation of the cell-cycle: a sentinel to alert the NK cells of dangers. Front Immunol (2013) 4:325.10.3389/fimmu.2013.00325 - DOI - PMC - PubMed
    1. Shibuya A, Campbell D, Hannum C, Yssel H, Franz-Bacon K, McClanahan T, et al. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity (1996) 4(6):573–8110.1016/S1074-7613(00)70060-4 - DOI - PubMed

Publication types

LinkOut - more resources

Full text links
Frontiers Media SA full text link Frontiers Media SA Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp